Two Sigma Securities, LLC Arbutus Biopharma Corp Transaction History

Two Sigma Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $47,354 - $65,828	21,235 New	21,235 $64,000
Q1 2018 May 15, 2018	SELL	$4.4 - $6.05 $49,693 - $68,328	-11,294 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.45 - $7.7 $5,833 - $10,094	-1,311 Reduced 10.4%	11,294 $57,000
Q3 2017 Nov 14, 2017	BUY	$3.4 - $7.0 $42,857 - $88,235	12,605	12,605 $78,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $468M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.